Roxyfoli 50 Syrup contains Roxithromycin 50mg, a macrolide antibiotic formulated to treat respiratory infections, pharyngitis, tonsillitis, and mild skin infections. It provides effective bacterial control and symptom relief in a patient-friendly syrup form.
Roxithromycin inhibits bacterial protein synthesis, ensuring rapid infection management while being gentle on children and adults. Syrup formulation allows easy dosing, palatability, and improved compliance, particularly in pediatric patients.
Roxyfoli 50 Syrup is widely recommended in clinics, hospitals, and pharmacies as a high-demand anti-infective therapy.
Adding Roxyfoli 50 Syrup to your anti-infective portfolio strengthens your offerings with a clinically trusted, fast-moving product. Its prescriber confidence, pediatric suitability, and export potential make it ideal for PCD pharma companies, distributors, and third-party manufacturing partners.
Common side effects may include nausea, vomiting, abdominal discomfort, mild diarrhea, or headache. Rare but serious side effects include allergic reactions, liver enzyme abnormalities, or severe gastrointestinal disturbances. Medical attention should be sought if serious or persistent symptoms occur.
Roxyfoli 50 Syrup is indicated for the treatment of respiratory tract infections such as bronchitis, pneumonia, sinusitis, pharyngitis, and other infections caused by Roxithromycin-sensitive bacteria, as prescribed by a healthcare professional.
Roxyfoli 50 Syrup should be taken exactly as prescribed, using a proper measuring device. Complete the full course of therapy to prevent bacterial resistance. Inform the doctor of any history of liver or kidney disease, heart conditions, or allergy to macrolide antibiotics.
Store Roxyfoli 50 Syrup in a cool, dry place away from direct sunlight. Shake well before use, keep the bottle tightly closed, and store out of reach of children. Do not use beyond the expiry date printed on the label.